Earnings Per Share
EPS (Basic)
Edwards Lifesciences EPS (Basic) increased by 312.5% to $0.66 in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 8.2%, from $0.61 to $0.66. Over 4 years (FY 2021 to FY 2025), EPS (Basic) shows a downward trend with a -6.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase indicates improved profitability or a reduction in share count, while a decrease suggests declining earnings or equity dilution.
Detailed definition
Basic earnings per share represents the portion of a company's profit allocated to each outstanding share of common stoc...
Peer comparison
Investors compare this across large-cap technology peers to assess the efficiency of earnings generation relative to the equity base.
Metric ID:
eps_basicHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.79 | $0.55 | $0.53 | $0.60 | $0.65 | $0.55 | $0.66 | $0.56 | $0.51 | $0.63 | $0.61 | $0.58 | $0.61 | $5.14 | $0.65 | $0.61 | $0.57 | $0.50 | $0.16 | $0.66 |
| QoQ Change | — | -30.4% | -3.6% | +13.2% | +8.3% | -15.4% | +20.0% | -15.2% | -8.9% | +23.5% | -3.2% | -4.9% | +5.2% | +742.6% | -87.4% | -6.2% | -6.6% | -12.3% | -68.0% | +312.5% |
| YoY Change | — | — | — | — | -17.7% | +0.0% | +24.5% | -6.7% | -21.5% | +14.5% | -7.6% | +3.6% | +19.6% | +715.9% | +6.6% | +5.2% | -6.6% | -90.3% | -75.4% | +8.2% |
Range$0.16 – $5.14
CAGR-3.7%
Avg YoY Growth+35.8%
Median YoY Growth+1.8%
EPS (Basic) at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's eps (basic)?
- Edwards Lifesciences (EW) reported eps (basic) of $0.66 in Q1 2026.
- How has Edwards Lifesciences's eps (basic) changed year-over-year?
- Edwards Lifesciences's eps (basic) increased by 8.2% year-over-year, from $0.61 to $0.66.
- What is the long-term trend for Edwards Lifesciences's eps (basic)?
- Over 4 years (2021 to 2025), Edwards Lifesciences's eps (basic) has grown at a -6.5% compound annual growth rate (CAGR), from $2.41 to $1.84.
- What does eps (basic) mean?
- The amount of profit a company makes for every single share of its common stock currently held by investors.